Source: Francesoir


Italy has been talked about a lot since the start of the Covid crisis in 2020 with first of all a significant mortality at the beginning of the year, followed at the end of the year by the decision of the Council of State to give following the request of doctors on early treatment at home including hydroxychloroquine , request made among others, by Dr Mangiagalli and Stramezzi .

Following a final publication by the group of doctors specialists of infectious diseases Piedmont, Dr. Garavelli and colleagues demonstrate the efficiency of hydroxychloroquine ( HCQ ) in the reduction of mortality in hospitalized patients. This study was published in the “  Journal of Clinical Medicine  ”.

In this debriefing, speaking in French, Dr. Garavelli looks back on the situation in his country as well as their study, thus taking the measure between the early treatment at home defended victoriously at the Italian Council of State, hospitalizations or intensive care Dr. Garavelli tells us that “ the treatment based on hydroxychloroquine is effective in the early phase of the disease at home or upon arrival at the hospital 

It also describes the antiviral but also immunomodulatory properties of HCQ. When the patient goes into intensive care, it is too late for this treatment because it is no longer the virus that has its effect but other pathologies take over.

He also reviews the dosage of hydroxychloroquine used (400mg for 7 or 14 days) and also refers to the overdose used in the Recovery (2400mg of HCQ in the first 24 hours) and Solidarity studies. It also discusses the use and efficacy of ivermectin as an antiviral and immuno- modulator.

Related: How hydroxychloroquine works at the cellular level

Hydroxychloroquine approved in Italy: the full scientific report

Covid-19, Early Treatment, and America’s Frontline Doctors – The Dr Urso Interview

How much proof do you want? Hundreds of studies conclude – treat Covid-19 early with hydroxychloroquine!

Nebulized Hydroxychloroquine for COVID-19 Treatment: 80x Improvement in Breathing – Dr Vladimir Zelenko

Turkey studies the impact of hydroxychloroquine-azithromycin combination – No significant heart QT prolongation found

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »